References
- Strauss RG. Therapeutic granulocyte transfusions in 1993. Blood 1993;81:1675–8.
- Strauss RG. Clinical perspectives of granulocyte transfusions: efficacy to date. J Clin Apher 1995;10: 114–8.
- Vamvakas EC, Pineda AA.Determinants of the efficacy of prophylactic granulocyte transfusions: a metaanalysis. J Clin Apher 1997;12:74–81.
- Dale DC, Fauci AS, Guerry D, Wolff SM. Comparison of agents producing a neutrophilic leukocytosis in man.J Clin Inves 1975;56:808–13.
- Liles WC, Huang JE, Llewellyn C, Sengupta D, Price TH, Dale DC.A comparative trial of granulocytecolony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal vol- unteers.Transfusion 1997;37:182–7.
- Leitman SF, Oblitas JM. Optimization of granulocyta- pheresis mobilization regimens using granulocyte stimulating factor (G-CSF) and dexamethasone. Transfusion 1997;37(Suppl):67S.
- de Haas M, Kleijer M,van Zweiten R, Roos D,von dem Borne AEGKr. Neutrophil FcγRIIIb deficiency, nature and clinical consequences: a study of 21 individuals from 14 families. Blood 1995;86:2403–13.
- Lord LI, Bronchud MH, Owens S,et al.The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc Natl Acad Sci USA 1989;86:9499–503.
- Bensinger WI, Price TH, Dale DC,et al.The effects of daily recombinant human granulocyte colony stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993;81: 1883–8.
- Caspar CB, Seger RA, Burger J, Gmur J. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood 1993;81:2866–71.
- Hester JP, Dignani MC, Anaissie EJ, Kantarjian HM, O’Brien S, Freireich EJ. Collection and transfusion of granulocyte concentrate from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infection. J Clin Apher 1995;10:188–93.
- Lane TA, Law P, Maruyama M,et al. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood 1995;85:275–82.
- Anderlini P, Przepiorka D, Seong D,et al. Clinical toxicity and laboratory effects of granulocyte-colonystimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors,and analysis of charges for the procedures. Transfusion 1996; 36:590–5.
- Anderlini P, Przepiorka D, Seong D, Champlin R, Korbling M.Transient neutropenia in normal donors after G-CSF mobilization and stem cell apheresis. Br J Haematol 1996;94:155–8.
- Stroncek DF, Clay ME, Petzoldt ML,et al.Treatment of normal individuals with G-CSF: donor experiences and the effects on peripheral blood CD34+ cell counts and the collection of peripheral blood stem cells.Transfusion 1996;36:601–10.
- Stroncek DF, Clay ME, Smith J, Ilstrup S, Oldham F, McCullough J. Changes in blood counts following the administration of G-CSF and the collection of peripheral blood stem cells from healthy donors. Transfusion 1996;36:596–600.
- Lee J-H, Leitman SF, Klein HG.A controlled comparison of the efficacy of hetastarch and pentastarch in granulocyte collections by centrifugal leukapheresis. Blood 1995;86:4662–6.
- Menitove JE, ed. Standards for blood banks and transfusion services. 18th ed. Bethesda, MD: American Association of Blood Banks, 1997.
- Lane TA,Windle B. Granulocyte concentrate function during preservation: effect of temperature. Blood 1979;54:216–25.
- McCullough J,Weiblen BJ, Fine D.Effects of storage of granulocytes on their fate in vivo. Transfusion 1983;23:20–4.
- Coates TD, Wolach B, Tzeng DY, Higgins C, Baehner RL, Boxer LA.The mechanisms of action of the antiinflammatory agents dexamethasone and auranofin in human polymorphonuclear leukocytes. Blood 1983;62:1070–7.
- Clark RAF, Gallin JI, Fauci AS. Effects of in vivo prednisone on in vitro eosinophil and neutrophil adherence and chemotaxis. Blood 1979;53:633–41.
- Fauci AS, Dale DC, Balow JE. Glucocorticosteroid therapy:mechanisms of action and clinical consider- ations.Ann Int Med 1976;84:304–15.
- Ward PA. The chemosuppression of chemotaxis. J Exp Med 1966;24:209–25.
- Glasser L, Huestis DW, Jones JF. Functional capabilities of steroid-recruited neutrophils harvested for clinical transfusion. N Engl J Med 1977;297:1033–6.
- Price TH, Dale DC. Blood kinetics and in vivo chemotaxis of transfused neutrophils: effects of collection method, donor corticoid treatment and short-term storage. Blood 1979;54:977–86.
- Kerst JM, de Haas M, van der Schoot CE, et al. Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells. Blood 1993;82:3265–72.
- Adkins D, Goodgold H, Hendershott L, Johnston M, Cravens D, Spitzer G. Indium-labeled white blood cells apheresed from donors receiving G-CSF localize to sites of inflammation when infused into allogeneic bone marrow transplant recipients. Bone Marrow Transplantation 1997;19:809–12.
- [29]Leitman SF, Oblitas JM, Emmons R, Dunn DE,Young NS. Clinical efficacy of daily G-CSF-recruited granulocyte transfusions in patients with severe neutropenia and life-threatening infections. Blood 1996;88:331a.
- McCullough J, Clay ME, Hurd D, Richards K, Ludvigsen C, Forstrom L. Effect of leukocyte antibodies and HLA matching on the intravascular recovery, survival, and tissue localization of 111-indium labeled granulocytes. Blood 1986;67:522–8.
- Weiblen BJ,Forstrom L, McCullough J. Studies of the kinetics of indium-111-labeled granulocytes. J Lab Clin Med 1979;94:246–55.
- Liles WC, Kiener PA, Ledbetter JA,Aruffo A,Klebanoff SJ. Differential expression of Fas (DC95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils.J Exp Med 1996;184:429–40.
- Liles WC, Dale DC, Klebanoff SJ. Glucocorticoids inhibit apoptosis of human neutrophils. Blood 1995;86:3181–8.
- Schiffer CA,Aisner J, Daly PA,et al.Alloimmunization following prophylactic granulocyte transfusions. Blood 1979;54:766–74.
- Stroncek DF, Leonard K, Eiber G, Malech HL, Gallin JI, Leitman SF.Alloimmunization after granulocyte trans- fusions.Transfusion 1996;36:1009–15.
- Goldstein IM, Eyre JH, Terasaki PI, Henderson ES, Graw RG Jr. Leukocyte transfusions: role of leukocyte alloantibodies in determining transfusion response. Transfusion 1971;11:19–24.
- Popovsky MA, Abel MD, Moore SB.Transfusion-relat- ed acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis 1983;128:185–9.
- Dutcher JP, Schiffer CA, Johnston GS, et al. Alloimmunization prevents the migration of transfused indium-111-labeled granulocytes to sites of infection. Blood 1983;62:354–60.
- DePalma L, Leitman SF, Carter CS, Gallin JI. Granulocyte transfusion therapy in a child with chronic granulomatous disease and multiple red cell antibodies.Transfusion 1989;29:421–3.
- Wright DG, Robichaud KJ, Pizzo PA, Deisseroth AB. Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med 1981;304:1185–9.
- Eastlund DT, Charbonneau TT. Superoxide generation and cytotactic response of irradiated neu- trophils.Transfusion 1988;26:368–70.